vs
Side-by-side financial comparison of Agilent Technologies (A) and CONSTELLIUM SE (CSTM). Click either name above to swap in a different company.
CONSTELLIUM SE is the larger business by last-quarter revenue ($2.2B vs $1.8B, roughly 1.2× Agilent Technologies). Agilent Technologies runs the higher net margin — 17.0% vs 5.1%, a 11.9% gap on every dollar of revenue. Agilent Technologies produced more free cash flow last quarter ($175.0M vs $109.0M).
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emissi...
Constellium SE is an American-Swiss, French-based global manufacturer of aluminium rolled products, extruded products, and structural parts based on a large variety of advanced alloys. Constellium's C-TEC research center has been credited for advancing technology in the field of advanced aluminium alloy. Constellium primarily serves the aerospace, automotive, and packaging sectors. Large clients include Mercedes-Benz, Audi, BMW, Fiat Chrysler Automotive, Ford, Airbus, Boeing, and Bombardier.
A vs CSTM — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.8B | $2.2B |
| Net Profit | $305.0M | $112.0M |
| Gross Margin | 52.6% | — |
| Operating Margin | 19.6% | 7.5% |
| Net Margin | 17.0% | 5.1% |
| Revenue YoY | 7.0% | — |
| Net Profit YoY | -4.1% | — |
| EPS (diluted) | $1.07 | $0.79 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $1.8B | — | ||
| Q4 25 | $1.9B | $2.2B | ||
| Q3 25 | $1.7B | $2.2B | ||
| Q2 25 | $1.7B | $2.1B | ||
| Q1 25 | $1.7B | $2.0B | ||
| Q4 24 | $1.7B | — | ||
| Q3 24 | $1.6B | — | ||
| Q2 24 | $1.6B | $1.9B |
| Q1 26 | $305.0M | — | ||
| Q4 25 | $434.0M | $112.0M | ||
| Q3 25 | $336.0M | $88.0M | ||
| Q2 25 | $215.0M | $36.0M | ||
| Q1 25 | $318.0M | $37.0M | ||
| Q4 24 | $351.0M | — | ||
| Q3 24 | $282.0M | — | ||
| Q2 24 | $308.0M | $76.0M |
| Q1 26 | 52.6% | — | ||
| Q4 25 | 53.2% | — | ||
| Q3 25 | 51.1% | — | ||
| Q2 25 | 51.9% | — | ||
| Q1 25 | 53.5% | — | ||
| Q4 24 | 53.9% | — | ||
| Q3 24 | 54.2% | — | ||
| Q2 24 | 54.4% | — |
| Q1 26 | 19.6% | — | ||
| Q4 25 | 23.8% | 7.5% | ||
| Q3 25 | 20.7% | 5.8% | ||
| Q2 25 | 18.0% | 2.7% | ||
| Q1 25 | 22.4% | 3.1% | ||
| Q4 24 | 24.0% | — | ||
| Q3 24 | 21.1% | — | ||
| Q2 24 | 23.1% | 5.4% |
| Q1 26 | 17.0% | — | ||
| Q4 25 | 23.3% | 5.1% | ||
| Q3 25 | 19.3% | 4.1% | ||
| Q2 25 | 12.9% | 1.7% | ||
| Q1 25 | 18.9% | 1.9% | ||
| Q4 24 | 20.6% | — | ||
| Q3 24 | 17.9% | — | ||
| Q2 24 | 19.6% | 3.9% |
| Q1 26 | $1.07 | — | ||
| Q4 25 | $1.53 | $0.79 | ||
| Q3 25 | $1.18 | $0.62 | ||
| Q2 25 | $0.75 | $0.25 | ||
| Q1 25 | $1.11 | $0.26 | ||
| Q4 24 | $1.23 | — | ||
| Q3 24 | $0.97 | — | ||
| Q2 24 | $1.05 | $0.51 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.8B | $120.0M |
| Total DebtLower is stronger | $3.0B | $1.9B |
| Stockholders' EquityBook value | $6.9B | $952.0M |
| Total Assets | $12.8B | $5.4B |
| Debt / EquityLower = less leverage | 0.44× | 2.00× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $1.8B | — | ||
| Q4 25 | $1.8B | $120.0M | ||
| Q3 25 | $1.5B | $122.0M | ||
| Q2 25 | $1.5B | $133.0M | ||
| Q1 25 | $1.5B | $118.0M | ||
| Q4 24 | $1.3B | — | ||
| Q3 24 | $1.8B | — | ||
| Q2 24 | $1.7B | — |
| Q1 26 | $3.0B | — | ||
| Q4 25 | $3.0B | $1.9B | ||
| Q3 25 | $3.4B | $2.0B | ||
| Q2 25 | $3.3B | $2.0B | ||
| Q1 25 | $3.3B | $1.9B | ||
| Q4 24 | $3.3B | — | ||
| Q3 24 | $2.1B | — | ||
| Q2 24 | $2.1B | — |
| Q1 26 | $6.9B | — | ||
| Q4 25 | $6.7B | $952.0M | ||
| Q3 25 | $6.4B | $845.0M | ||
| Q2 25 | $6.1B | $780.0M | ||
| Q1 25 | $6.0B | $745.0M | ||
| Q4 24 | $5.9B | — | ||
| Q3 24 | $5.9B | — | ||
| Q2 24 | $6.2B | $796.0M |
| Q1 26 | $12.8B | — | ||
| Q4 25 | $12.7B | $5.4B | ||
| Q3 25 | $12.2B | $5.4B | ||
| Q2 25 | $12.2B | $5.4B | ||
| Q1 25 | $11.9B | $5.2B | ||
| Q4 24 | $11.8B | — | ||
| Q3 24 | $11.0B | — | ||
| Q2 24 | $10.9B | — |
| Q1 26 | 0.44× | — | ||
| Q4 25 | 0.45× | 2.00× | ||
| Q3 25 | 0.53× | 2.34× | ||
| Q2 25 | 0.55× | 2.53× | ||
| Q1 25 | 0.56× | 2.56× | ||
| Q4 24 | 0.57× | — | ||
| Q3 24 | 0.36× | — | ||
| Q2 24 | 0.34× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $268.0M | $218.0M |
| Free Cash FlowOCF − Capex | $175.0M | $109.0M |
| FCF MarginFCF / Revenue | 9.7% | 5.0% |
| Capex IntensityCapex / Revenue | 5.2% | 5.0% |
| Cash ConversionOCF / Net Profit | 0.88× | 1.95× |
| TTM Free Cash FlowTrailing 4 quarters | $993.0M | $159.0M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $268.0M | — | ||
| Q4 25 | $545.0M | $218.0M | ||
| Q3 25 | $362.0M | $99.0M | ||
| Q2 25 | $221.0M | $114.0M | ||
| Q1 25 | $431.0M | $58.0M | ||
| Q4 24 | $481.0M | — | ||
| Q3 24 | $452.0M | — | ||
| Q2 24 | $333.0M | $138.0M |
| Q1 26 | $175.0M | — | ||
| Q4 25 | $452.0M | $109.0M | ||
| Q3 25 | $259.0M | $24.0M | ||
| Q2 25 | $107.0M | $37.0M | ||
| Q1 25 | $334.0M | $-11.0M | ||
| Q4 24 | $388.0M | — | ||
| Q3 24 | $360.0M | — | ||
| Q2 24 | $230.0M | $54.0M |
| Q1 26 | 9.7% | — | ||
| Q4 25 | 24.3% | 5.0% | ||
| Q3 25 | 14.9% | 1.1% | ||
| Q2 25 | 6.4% | 1.8% | ||
| Q1 25 | 19.9% | -0.6% | ||
| Q4 24 | 22.8% | — | ||
| Q3 24 | 22.8% | — | ||
| Q2 24 | 14.6% | 2.8% |
| Q1 26 | 5.2% | — | ||
| Q4 25 | 5.0% | 5.0% | ||
| Q3 25 | 5.9% | 3.5% | ||
| Q2 25 | 6.8% | 3.7% | ||
| Q1 25 | 5.8% | 3.5% | ||
| Q4 24 | 5.5% | — | ||
| Q3 24 | 5.8% | — | ||
| Q2 24 | 6.5% | 4.3% |
| Q1 26 | 0.88× | — | ||
| Q4 25 | 1.26× | 1.95× | ||
| Q3 25 | 1.08× | 1.13× | ||
| Q2 25 | 1.03× | 3.17× | ||
| Q1 25 | 1.36× | 1.57× | ||
| Q4 24 | 1.37× | — | ||
| Q3 24 | 1.60× | — | ||
| Q2 24 | 1.08× | 1.82× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
A
| Service Other | $525.0M | 29% |
| Chemicaland Energy Market | $422.0M | 23% |
| Agilent Cross Lab | $273.0M | 15% |
| Environmentaland Forensics Market | $177.0M | 10% |
| Food Market | $166.0M | 9% |
| Academiaand Government Market | $130.0M | 7% |
| Applied Markets | $98.0M | 5% |
CSTM
| Packaging Rolled Products | $1.0B | 46% |
| Automotive Rolled Products | $318.0M | 14% |
| Aerospace Rolled Products | $270.0M | 12% |
| Transportation Industry Defense And Other Rolled Products | $232.0M | 11% |
| Automotive Extruded Products | $220.0M | 10% |
| Other Extruded Products | $132.0M | 6% |
| Specialty And Other Thin Rolled Products | $22.0M | 1% |
